Atlas Trials

Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

Clinical trial NCT02944617 · COMPLETED

Trial details

NCT number
NCT02944617
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DiarrheaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer
Start date
2016-11-11
Primary completion
2021-12-19
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.